Drug firm Lupin today said it has launched a generic version of Pennsaid, used to treat pain in the knees caused by osteoarthritis in the American market.
The company’s product — Diclofenac Sodium Topical Solution 2 per cent — is the generic version of Horizon Pharma Therapeutics Pennsaid, Lupin said in a statement.
As per IQVIA MAT October 2022 data, Lupin said diclofenac sodium topical solution, 2 per cent, had estimated annual sales of $509 million in the US.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Featured Video Of The Day
Tech Layoffs Globally, But Big Hiring In Fintech And E-Commerce In Chennai